Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CTXR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
8 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 5
43 filers reported a long position in CTXR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $130.3K | 215.5K | -12.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $119.4K | 197.4K | +17.7% |
| Miller Financial Services LLC | $78.6K | 130K | +828.6% |
| CITADEL ADVISORS LLC | $75.5K | 124.9K | New |
| JANE STREET GROUP, LLC | $74.3K | 122.8K | +445.4% |
| VANGUARD FIDUCIARY TRUST CO | $47K | 77.8K | Unchanged |
| BlackRock, Inc. | $42.2K | 69.9K | 0% |
| NORTHERN TRUST CORP | $37.9K | 62.7K | +42.7% |
| XTX Topco Ltd | $35.8K | 59.2K | +178% |
| Asset Advisory Group, Inc. | $35.7K | 59K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.